Food allergies are on the rise,
with significant social, health, and economic impact
$25B
Each year is spent on healthcare costs related to food allergies and disorders
1 in every 13 children in
the United States is affected by food allergies
Every 3 minutes anaphylaxis sends someone to the E.R.
Ukko uses its computational protein design platform to develop a pipeline of revolutionary therapeutics for life threatening allergies: modulating the immune system of allergic patients without triggering allergy
We are building a clinically validated map of the molecular interaction between the allergen and the patient's immune system: unlocking critical knowledge about the biological mechanisms that drive human-food interactions
Using this map, we then use our AI micro-engineering platform to design new versions of the allergen that do not trigger an allergic response but still re-educate the immune system to tolerate the allergen. This allows for a whole new approach to treating allergies
Founding Team
ANAT BINUR
CEO & Co-Founder
YANAY OFRAN
Chairman & Co-Founder
Our Advisors
DR. DANIEL ADELMAN - Ukko's acting CMO;
Former CMO of Aimmune Therapeutics, Alvine Pharmaceuticals & Sunesis;
Advisory board at FARE
DR. TIM GARNETT
Former CMO and SVP, Eli-Lily
DR. WESLEY A. BURKS
Stuart Bondurant Distinguished Professor
Dean and CEO UNC School of Medicine and UNC Health
DR. JAMES BAKER
Founding Director of
H. Weiser Food Allergy Center, Michigan University; CEO & CMO at FARE
PROF. STEPHEN DRESKIN
Medical Director, Allergy and Clinical Immunology
Professor of Medicine and Immunology
Children’s Hospital Colorado
PROF. LYNDA SCHNEIDER
Director, Allergy Program
Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School
DR. EDWIN KIM
Associate Professor, University of North Carolina; Director UNC Food Allergy Initiative
PROF. RAANAN SHAMIR
Chairman, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center
